Related Experiment Video
Updated: Jun 26, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
2.8K
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and
David Pesqué1,2, Leopoldo Borrego3, Violeta Zaragoza-Ninet4
1Department of Dermatology, Hospital del Mar Research Institute, Barcelona, Spain.
Journal of the European Academy of Dermatology and Venereology : JEADV
|February 27, 2024
Summary
Polysensitization (PS) affects 8.3% of patients, with specific allergen clusters identified. Risk factors include atopic dermatitis and older age, suggesting cross-reactivity patterns in allergic contact dermatitis.
Area of Science:
- Dermatology
- Allergology
- Epidemiology
Background:
- Limited clinical data exists on allergen clusters in polysensitization (PS).
- Understanding PS features and risk factors is crucial for effective management.
Purpose of the Study:
- To determine the frequency, relevance, symptom duration, and risk factors of PS.
- To assess allergen aggregation patterns in polysensitized patients.
Main Methods:
- A prospective multicentric study analyzed 10,176 patients from the Spanish Contact Dermatitis Register (REIDAC).
- Logistic regression identified PS risk factors.
- Unsupervised hierarchical clustering and network analysis explored allergen aggregation.
Main Results:
- Polysensitization (PS) was identified in 8.3% of patients.
- Risk factors for PS included atopic dermatitis, age over 60, and specific body locations (legs, hands, arms, trunk).
- Cluster analysis revealed significant allergen associations within metals, fragrances, botanicals, topical drugs, rubber, and biocides.
Conclusions:
- Polysensitization (PS) exhibits distinct allergen cluster patterns.
- Significant allergen associations in PS suggest cross-reactivity or concomitant sensitization.
Related Concept Videos
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...